Diminished expression of HLA-ABC (~80% reduction in expression; Fig. 4C) was driven by two independent B2M-targeting silencing molecules and this significantly reduced the immune recognition of melanoma cells, leading to approximately a 70% reduction in the levels of IFNγ production (Fig. 4C). The gene discussed is IFNG; the disease is melanoma.